The efficacy of quantitative gait analysis by the GAITRite system in evaluation of parkinsonian bradykinesia

Parkinsonism and Related Disorders

Volumn 12, Issue 7, 2006, Pages 438-442

  Chien, Shih Lin ^a   Lin, Shinn Zong ^b   Liang, Chung Chao ^a   Soong, Yi Sheng ^a   Lin, Sheng Huang ^a   Hsin, Yu Loong ^a   Lee, Chi Wei ^b   Chen, Shin Yuan ^b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Bradykinesia; Gait; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; ELECTRONIC SENSOR; GAIT; HUMAN; ON OFF PHENOMENON; PARKINSONISM; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTEM ANALYSIS; VELOCITY; WALKING;

ADULT; ANTIPARKINSON AGENTS; DIAGNOSIS, COMPUTER-ASSISTED; DISABILITY EVALUATION; GAIT; HUMANS; HYPOKINESIA; LEVODOPA; MIDDLE AGED; PARKINSON DISEASE;

EID: 33748758166     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.04.004     Document Type: Article

References (23)

1. Nieuwboer A., De Weerdt W., Dom R., and Lesaffre E. A frequency and correlation analysis of motor deficits in Parkinson patients. Disabil Rehabil 2 (1998) 142-150
2. Garcia Ruiz P.J., Meseguer E., Del Val J., Vazquez A., Sanchez Bernardos V., and Vazquez A. Motor complications in Parkinson disease: a prospective follow-up study. Clin Neuropharmacol 27 (2004) 49-52
3. Cutson T.M., Laub K.C., and Schenkman M. Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease. Phys Ther 75 (1995) 363-373
4. Lyons K.E., and Pahwa R. Deep brain stimulation in Parkinson's disease. Curr Neurol Neurosci Rep 4 (2004) 290-295
5. Montgomery Jr. E.B. Rehabilitative approaches to Parkinson's disease. Parkinsonism Relat Disord 10 suppl. 1 (2004) S43-S47
6. Ramaker C., Marinus J., Stiggelbout A.M., and Van Hilten B.J. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Movement Disord 17 (2002) 867-876
7. Movement disorder society task force on rating scales for Parkinson's disease. The united Parkinson's disease rating scale (UPDRS): status and recommendations. Movement Disord 18 (2003) 738-750
8. Bowes S.G., Clark P.K., Charlett A., O'Neill C.J., Leeman A.L., Weller C., et al. Objective outcome criteria in trials of anti -parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia. Br J Clin Pharmacol 31 (1991) 295-304
9. Peschanski M., Defer G., N'Guyen J.P., Ricolfi F., Monfort J.C., Remy P., et al. Bilateral motor improvement and alteration of l-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117 (1994) 487-499
10. Klenerman L., Dobbs R.J., Weller C., Leeman A.L., and Nicholson P.W. Bringing gait analysis out of the laboratory and into the clinic. Age Ageing 17 (1988) 397-400
11. O'Sullivan J.D., Said C.M., Dillon L.C., Hoffman M., and Hughes A.J. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function. Movement Disord 13 (1998) 900-906
12. Stolze H., Klebe S., Poepping M., Lorenz D., Herzog J., Hamel W., et al. Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology 57 (2001) 144-146
13. Uden C.J.T., and Besser M. Test-retest reliability of temporal and spatial gait characteristics measured with an instrumented walkway system (GAITRite). BMC Musculoskelet Disord 5 (2004) 13-16
14. McDonough A.L., Betavia M., Chen F.C., Kwon S., and Zia J. The validity and reliability of the GAITRite system's measurements: a preliminary evaluation. Arch Phys Med Rehabil 82 (2001) 419-425
15. Nelson A.J., Zwick D., Brody S., Doran C., Pulver L., Rooz G., et al. The validity of the GaitRite and the Functional Ambulation Performance scoring system in the analysis of Parkinson gait. Neurorehabilitation 17 (2002) 255-262
16. Ashwini K.R., Lori Q., and Karen S.M. Reliability of spatiotemporal gait outcome measures in Huntington's disease. Movement Disord 20 (2005) 1033-1037
17. Shan D.E., Lee S.J., Chao L.Y., and Yeh S.I. Gait analysis in advanced Parkinson's disease-effect of levodopa and tolcapone. Can J Neurol Sci 28 (2001) 70-75
18. Stolze H., Kuhtz-Buschbeck J.P., Drucke H., Johnk K., Illert M., and Deuschl G. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatr 70 (2001) 289-297
19. Morris M.E., Iansek R., Matyas T.A., and Summers J.J. The pathogenesis of gait hypokinesia in Parkinson's disease. Brain 117 (1994) 1169-1181
20. Hanakawa T., Fukuyama H., Yukinori Katsumi Y., Honda M., and Shibasak H. Enhanced lateral premotor activity during paradoxical gait in Parkinson's disease. Ann Neurol 45 (1994) 329-336
21. Vokaer M., Azar N.A., and de Beyl D.Z. Effects of levodopa on upper limb mobility and gait in Parkinson's disease. J Neurol Neurosurg Psychiatr 74 (2003) 1304-1307
22. Ng S.S., and Hui-Chan C.W. The timed up & go test: its reliability and association with lower-limb impairments and locomotor capacities in people with chronic stroke. Arch Phys Med Rehabil 86 (2005) 1641-1647
23. Webster K.E., Wittwer J.E., and Feller J.A. Validity of the GAITRite walkway system for the measurement of averaged and individual step parameters of gait. Gait Posture 22 4 (2005) 317-321